Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 11—November 2004


Enhanced Identification of Postoperative Infections among Inpatients

Deborah S. Yokoe*Comments to Author , Gary A. Noskin†, Susan M. Cunningham†, Gianna Zuccotti‡, Theresa Plaskett‡, Victoria J. Fraser§, Margaret A. Olsen§, Jerome I. Tokars¶, Steven Solomon¶, Trish M. Perl#, Sara E. Cosgrove#, Richard S. Tilson*, Maurice Greenbaum**, David C. Hooper††, Kenneth E. Sands‡‡, John Tully§§, Loreen A. Herwaldt¶¶, Daniel J. Diekema¶¶, Edward S. Wong##, Michael Climo##, and Richard Platt***
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Northwestern University, Chicago, Illinois, USA; ‡Memorial Sloan-Kettering Cancer Center, New York, New York, USA; §Washington University School of Medicine, St. Louis, Missouri, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; **North Shore Medical Center-Salem Hospital, Salem, Massachusetts, USA; ††Massachusetts General Hospital, Boston, Massachusetts, USA; ‡‡Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; §§Mount Auburn Medical Center, Cambridge, Massachusetts, USA; ¶¶University of Iowa Carver College of Medicine, Iowa City, Iowa, USA; ##McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA; ***Harvard Pilgrim Health Care, Boston, Massachusetts, USA

Main Article

Table 4

Percentage of patients who met the antimicrobial drug, diagnosis code–screening criteria, or both, after CABG procedures, cesarean delivery, and breast proceduresa

Procedure and phase % of patients meeting
Antimicrobial exposure criteria Diagnosis code criteria Antimicrobial exposure
or diagnosis code criteria
Phase 1 15.2 4.5 15.8
Phase 2 19.1 4.6 19.6
Cesarean delivery
Phase 1 8.8 3.2 9.5
Phase 2 12.7 6.4 14.1
Breast procedures
Phase 1 3.5 0.8 3.7
Phase 2 6.7 2.0 6.8

aCABG, coronary artery bypass graft.

Main Article